morphiceptin, n-me-phe(3)- has been researched along with omega-agatoxin iva in 1 studies
| Studies (morphiceptin, n-me-phe(3)-) | Trials (morphiceptin, n-me-phe(3)-) | Recent Studies (post-2010) (morphiceptin, n-me-phe(3)-) | Studies (omega-agatoxin iva) | Trials (omega-agatoxin iva) | Recent Studies (post-2010) (omega-agatoxin iva) |
|---|---|---|---|---|---|
| 95 | 1 | 1 | 420 | 0 | 22 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moises, HC; Rusin, KI | 1 |
1 other study(ies) available for morphiceptin, n-me-phe(3)- and omega-agatoxin iva
| Article | Year |
|---|---|
mu-Opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Drug Interactions; Endorphins; Ganglia, Spinal; Membrane Potentials; Mollusk Venoms; Neurons, Afferent; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Patch-Clamp Techniques; Peptides; Rats; Receptors, Opioid, mu; Spider Venoms | 1995 |